Xencor to Participate at Upcoming Investor Conferences
Xencor, Inc. (XNCR)
Last xencor, inc. earnings: 2/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.xencor.com/investor-relations
Company Research
Source: Business Wire
PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced that company management will participate at multiple upcoming investor conferences:Piper Sandler 36th Annual Healthcare ConferenceDate: Tuesday, December 3, 2024Presentation Time: 2:00 p.m. ET / 11:00 a.m. PTLocation: New York City7th Annual Evercore HealthCONx ConferenceDate: Wednesday, December 4, 2024Presentation Time: 3:50 p.m. ET / 12:50 p.m. PTLocation: Coral Gables, FloridaLive webcasts of the presentations will be available under “Events & Presentations” in the Investors section of the Company’s website located at www.xencor.com. Replays of the events will be available on the Xencor website for at least 30 days following the presentations.About XencorXencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients w
Show less
Read more
Impact Snapshot
Event Time:
XNCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XNCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XNCR alerts
High impacting Xencor, Inc. news events
Weekly update
A roundup of the hottest topics
XNCR
News
- Xencor, Inc. (NASDAQ: XNCR) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $37.00 price target on the stock.MarketBeat
- Wall Street Analysts Think Xencor (XNCR) Could Surge 31.58%: Read This Before Placing a Bet [Yahoo! Finance]Yahoo! Finance
- Xencor, Inc. (NASDAQ: XNCR) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $30.00 price target on the stock, up previously from $20.00.MarketBeat
- Xencor to Participate at Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Xencor: Plamotamab NHL Data Leads To RA Program Advancement [Seeking Alpha]Seeking Alpha
XNCR
Earnings
- 11/6/24 - Beat
XNCR
Sec Filings
- 12/4/24 - Form 4
- 12/4/24 - Form 144
- 12/2/24 - Form 144
- XNCR's page on the SEC website